Biotech · Private company
Novita Pharmaceuticals, Inc.
Track this companyFree. Adds Novita Pharmaceuticals, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials31 recruiting or active
Pipeline programs6From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline6
- NP-G2-044Phase 3 · Platinum-resistant Ovarian CancerClinicalTrials.gov · fetched Nov 12, 2026
- PLDPhase 3 · Platinum-resistant Ovarian CancerClinicalTrials.gov · fetched Nov 12, 2026
- Anti-PD-1 TherapyPhase 2 · Advanced or Metastatic Solid Tumor MalignanciesClinicalTrials.gov · fetched Nov 12, 2026
- NP-G2-044 Combination therapyPhase 2 · Advanced or Metastatic Solid Tumor MalignanciesClinicalTrials.gov · fetched Nov 12, 2026
- NP-G2-044 MonotherapyPhase 2 · Advanced or Metastatic Solid Tumor MalignanciesClinicalTrials.gov · fetched Nov 12, 2026
- NP-G2-044Phase 1 · Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Trial of NP-G2-044 (Prilukae) Combined With PLD for Treatment of Platinum-Resistant Ovarian Cancer (ULTIMUS-1)PHASE2_PHASE3 · ACTIVE_NOT_RECRUITING · started Dec 29, 2025ClinicalTrials.gov NCT07109414 · fetched Nov 12, 2026
- NP-G2-044 as Monotherapy and Combination Therapy in Patients With Advanced or Metastatic Solid Tumor MalignanciesPHASE1_PHASE2 · COMPLETED · started Dec 7, 2021ClinicalTrials.gov NCT05023486 · fetched Nov 12, 2026
- Clinical Trial of Metastasis Inhibitor NP-G2-044 in Patients With Advanced or Metastatic Treatment-Refractory Solid Tumor MalignanciesPHASE1 · COMPLETED · started Dec 21, 2017ClinicalTrials.gov NCT03199586 · fetched Nov 12, 2026